Using advanced computer techniques to study cancer development and progression.
Multiscale Computational Oncology Research Core
['FUNDING_OTHER'] · UNIVERSITY OF TX MD ANDERSON CAN CTR · NIH-10922847
This study is looking at how pancreatic cancer develops by using advanced computer techniques to analyze tiny details of cancer cells, helping us understand how they change from early stages to more serious forms, and it’s aimed at anyone interested in learning more about this type of cancer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TX MD ANDERSON CAN CTR (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10922847 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing our understanding of cancer, particularly pancreatic cancer, through advanced computational methods. It involves analyzing single-cell and genomic data to identify how cancer cells evolve from pre-malignant stages to invasive forms. The project utilizes cutting-edge three-dimensional imaging technologies and develops new algorithms to improve data analysis and interpretation. By bridging different scales of biological processes, the research aims to uncover the mechanisms driving cancer progression and intercellular interactions that contribute to tumor development.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic cancer or those at high risk for developing this disease.
Not a fit: Patients with cancers other than pancreatic cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for early detection and treatment of pancreatic cancer.
How similar studies have performed: Previous research has shown promise in using computational methods and single-cell analysis to advance cancer understanding, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TX MD ANDERSON CAN CTR — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FERTIG, ELANA — UNIVERSITY OF TX MD ANDERSON CAN CTR
- Study coordinator: FERTIG, ELANA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Biology, Cancers